微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Fulcrum Therapeutics (NASDAQ:FULC) +125%
Exagen (NASDAQ:XGN) +24%
Myomo (NYSE:MYO) +16%
IMV (NASDAQ:IMV) +8%
Allied Healthcare Products (NASDAQ:AHPI) +6%
Losers:...查看全文
格隆汇3月14日丨Myomo(MYO.US)盘前继续上涨8.44%,报0.835美元,该股月内累计涨幅近20%,且昨日涨4%创阶段新高。公司2022年Q4财报实现营收404.2万美元,前值为403.2万美元,预期值为406万美元;每... 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-031714 Size: 4 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-031703 Size: 6 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-031640 Size: 4 KB 网页链接
$Myomo(MYO)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001193125-22-153498 Act: 34 Size: 86 KB 网页链接
$Myomo(MYO)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-019527 Act: 34 Size: 5 MB 网页链接
$Myomo(MYO)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001193125-22-147509 Act: 34 Size: 283 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-026720 Size: 8 KB 网页链接
$Myomo(MYO)$ DEF 14A Other definitive proxy statements Accession Number: 0001193125-22-130675 Act: 34 Size: 460 KB 网页链接
$Myomo(MYO)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-22-130696 Act: 34 Size: 312 KB 网页链接
$Myomo(MYO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-022670 Size: 8 KB 网页链接